Meituan Hits Debt Market With $2.5 Billion Bond Offer
By P.R. Venkat
Meituan, China's leading shopping-and-delivery platform, plans to raise $2.5 billion by issuing bonds, proceeds of which will be used the refinance offshore debt.
The company plans to issue $1.2 billion in notes due April 2028 and another $1.3 billion maturing in October 2029.
The coupon on these bonds will be 4.500% and 4.625%, respectively, Meituan said Wednesday.
Although the new senior notes have a higher interest rate, the impact on Meituan is likely to be limited given the strength of its core local commerce operating profit, Jefferies equity analysts Thomas Chong and Zoey Zong said in a note.
Meituan said it could redeem the notes before their maturity dates and that issuance of the notes wouldn't restrict its ability to incur additional debt.
Part of the proceeds will also be used to meet general corporate needs, it said.
Fitch Ratings has assigned a BBB rating to the U.S. dollar notes and said that the Chinese e-commerce company's recent upgrade reflects improvement in profitability and strong free cash flow generation ability due to successful strategy execution.
"We expect Meituan to generate strong FCF (free cash flow) over the medium term. It is unlikely to make any significant asset-heavy investments in the near term," Fitch said.
Goldman Sachs, BofA Securities, and Morgan Stanley are among the banks advising Meituan on the debt sales.
Write to P.R. Venkat at venkat.pr@wsj.com
(END) Dow Jones Newswires
September 24, 2024 21:41 ET (01:41 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks